AI assistant
Sanofi — AGM Information 2010
Apr 30, 2010
1643_iss_2010-04-30_708111e1-c809-4b0b-a61d-5d56f6a0ad05.pdf
AGM Information
Open in viewerOpens in your device viewer
Paris, France, April 30, 2010
Board of Directors
Combined General Meeting of May 17, 2010
Following the withdrawal by Catherine Bréchignac of her candidature for the position of Director on the sanofi-aventis Board of Directors for personal reasons, the sanofi-aventis Board of Directors meeting held on April 28, 2010 resolved not to propose a new director to the general shareholders meeting. As a result, the sixth resolution is moot, and is deleted with no effect on the numbering of the remaining resolutions. The agenda has been modified accordingly.
The convening notice is published in the April 30, 2010 issue of the Bulletin des Annonces Légales Obligatoires, and is available on the Company website at: en.sanofi-aventis.com (under Investors/General Meeting 2010).
About sanofi-aventis
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, please visit: www.sanofi-aventis.com.
Contact :
Investor Relations Tel: + 33 (0)1 53 77 45 45 174, avenue de France - 75013 Paris
1 / 1